...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: 3 Weeks To The 31st
4
Mar 10, 2017 10:17AM

SanFran,

I agree that it would be great if we received some new information in conjunction with this abstract about the clinical efficacy of ZEN-3694.

Keep in mind that although the abstract embargo is lifted on Friday March 31, Zenith doesn't present their poster until Monday April 3. The poster/presentation may contain updated or additional information that was not included in the abstract, which had to be submitted in January. A lot can change in a couple of months!

So I would wait until Monday April 3 to make a judgement, just in case a news release tags along with the April 3 presentation.

BearDownAZ

4
Mar 10, 2017 05:46PM
3
Mar 15, 2017 09:21AM
Share
New Message
Please login to post a reply